WeedLife News Network

LOS ANGELES, CA / ACCESSWIRE / August 17, 2021 / Buzz around INTEGRATED NATIONAL RESOURCES INC.'s WeedGenics continues to grow both in the cannabis industry and now the mainstream business world as well. Named by "Global Business Leaders Magazine" as one of the 20 innovative companies to know in 2021, the company was featured by the Atlanta, GA-based publication both in print and online thanks to WeedGenics' place as the manufacturing partner of choice for premium medical marijuana products.

The state Medical Marijuana Advisory Board voted Tuesday to reject five requests to add to the list of conditions that qualify people for medical marijuana, even while board members acknowledged that, in several cases, patients with the conditions could benefit from using medical cannabis.

The board rejected bids to allow medical marijuana to be used to treat traumatic brain injury, hepatitis, Hepatitis C, chronic insomnia that isn’t responding to other treatments and major depressive disorder that isn’t responding to other treatments.

Pennsylvania’s 367,925 active medical marijuana patients have all been diagnosed as having one or more of 23 serious medical conditions, including amyotrophic lateral sclerosis, anxiety disorder, cancer, Crohn’s disease, multiple sclerosis, post-traumatic stress disorder and opioid use disorder and chronic pain.

A move to amend the applications by the board was stymied by the board’s own policies.

Under the board’s existing policies, board members don’t have the option to amend an application submitted to them – the board must either refer the proposed new condition to one of its subcommittees to recommend the change or the board can notify the applicants to resubmit the request with the changes sought by the board, said Carol Mowery, assistant legal counsel for the Department of Health.

STRATHROY, Ontario, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co”, “we”, “us” or the “Company”) (TSX-V: EVE; OTCQX: EEVVF), is pleased to announce that its wholly-owned subsidiary, Natural MedCo Ltd. (“NMC”) has successfully entered into a Medical Cannabis Supply and Purchase Agreement (the “Agreement”) with TCann Pty Ltd., Australia (“TCann”), an import/export and distribution company of para-pharmaceutical, medicinal and narcotic products located in Thornleigh, New South Wales.

These days, there are numerous reasons why you should be cutting back on your alcohol consumption.

For one, we’ve long known that it causes several illnesses including heart disease and cancer and two, with the pandemic, alcohol can compromise your immune system. During the pandemic, so many people took up the habit of drinking at home, during Zoom parties, and these so-called “quarantinis” can have a majorly negative impact on our health – at a time when we need it more than ever.

Excessive consumption of booze can turn around our lives for the worse. It can cause domestic abuse problems, and affect our families as well as personal relationships. However, a tip over the edge can turn a booze lover into a full-fledged alcoholic, which is already advanced abuse of alcohol.

If you’re having a hard time cutting back on your drinks, new research supports the hypothesis that cannabis can help – in more ways than one.

Learn Sativa University's curriculum includes marijuana history, laws, careers, growing procedures, and even popular cookbook recipes. Photo Courtesy of Learn Sativa University

The University of Florida has the Swamp, Notre Dame has Touchdown Jesus, Clemson University has Death Valley, and Learn Sativa University, a cannabis college in Apopka, Florida, has a five-acre weed farm.

“We received reports from a local factory of a strong smell of cannabis permeating through the building. It transpires it was being taken in via air-conditioning systems.”

Police in the U.K. were called after the smell of cannabis was brought inside a local factory by linked air-conditioning units.

Officers went to the factory’s rooftop and were able to determine where the smells were coming from by a “process of deduction,” eventually seizing about £200,000 ($350,000) worth of cannabis from two nearby properties, reports Yorkshire Live.

The bust was part of a string of arrests in the area over the last week, with officers seizing just under £1 million ($1,741,402) worth of cannabis.

Earlier this year, police in Scotland busted a $1 million illegal grow-op after the smell of weed and sound of fans led them to inspect a warehouse.

These companies are securing their future by becoming indispensable to their customers.

Over drinks with his alleged accomplice Saturday night, an off-duty Portland firefighter decided to “teach a lesson’' to a man who he had learned reportedly burglarized the marijuana dispensary he owned, according to police, prosecutors and state records.

Meanwhile, an Uber driver had called police at 10:39 p.m. Saturday and reported seeing a man forced at gunpoint into a black Range Rover near Southwest Taylor Street and Broadway. The man being forced into the SUV unsuccessfully tried to brace himself against the door frame to avoid being pushed inside the vehicle, the Uber driver told police, according to the affidavit.

The Uber driver and the victim’s friends confirmed that the occupants of the stopped Range Rover were involved in the abduction, Molina wrote in the affidavit.

Police searched inside Oregon Hemp House for the man abducted but didn’t find him there either, according to the affidavit.

Lee, when interviewed by two Portland police detectives, said that Bourland had learned that a man had recently burglarized his business and had stolen marijuana, according to the affidavit.

Cannabis companies still have to be concerned about social media marketing, and in fact, any kind of social media presence.

Cannabis reform may be progressing in America, but access on social media remains an uncertain landscape. While brands have thrived, reaching millions of followers and verified status, many others have been cut short, suspended and deleted along the way.

Even those succeeding appear only to have a glimmer of an idea about what’s right and wrong when marketing cannabis. With so much uncertainty, brands proceed cautiously in a direction that may or may not be the correct path. 

San Bernardino County Sheriff, Shannon Dicus, Sent out a letter to local legislators today.

Legislation to legalize cannabis at the federal level recently proposed by Sen. Chuck Schumer (D-N.Y.) and a group of Senate Democrats is long overdue. While it aims to fix injustices done to communities of color that have been most harmed by the war on drugs, it excludes one very important demographic: patients.

The bill is presented as “comprehensive” cannabis reform. It makes cannabis legal in the United States for recreational use and has many provisions for expanding the cannabis industry. It also adds taxes that provide revenue to the federal government and stipulates that some of the money collected be used to enhance the lives of communities that have been most hurt by the failed war on drugs.

Leaving out patient care overlooks the largest group of people who will or may be affected by this new law.

An estimated 115 million Americans over age 50 will develop one or more illnesses such as osteoarthritis, anxiety, insomnia, or cancer that are treatable with cannabinoid medicines. Not providing for them in the discussion draft underscores that lawmakers are not paying attention to the needs of patients, the ways in which patients differ from recreational users, and the ways in which a recreational paradigm does not support needed clinical care.

First, legislation should decouple medical and recreational cannabis. While legalization of recreational cannabis may address the needs of healthy people, it does not address people’s medical needs. People need competent care based on sound science that is aligned with the same fundamental values that apply in all areas of medicine, including respect for patient choices through informed consent, beneficence through sound medical advice that ensures patients benefit while minimizing harm, issuing exact prescriptions to ensure that patients get the right medicine, and justice by ensuring that everyone is treated fairly and all have the same treatment opportunities.

As more states are legalizing recreational and medical cannabis across the United States, the cannabis market is growing.

But as more people consume cannabis, potential adverse events to the plant are becoming evident, including cannabis allergy.

What Is Cannabis Allergy?

Some cannabis consumers may suffer from a cannabis allergy, which is a body reaction to the cannabis plant. It has recently become relevant because of recent legalization in the U.S. and Canada.

Although the study on cannabis allergy is still in its infancy, we can outline its most relevant characteristics.

Cannabis sensitization is not so rare. Humans can be allergic to almost anything, and it is even possible to have multiple allergies. People may be exposed to hempseed hidden in foods and drinks. However, they may also suffer from sensitization by inhaling, smoking, touching, and eating cannabis.

Jazz Pharmaceuticals (NASDAQ: JAZZ) is a cross between a pharmaceutical stock and a cannabis stock. In its earlier life, it was a pharmaceutical company that was chugging along and posting some good numbers. But after it acquired GW Pharmaceuticals earlier this year, that changed. Now that it owns the only cannabis-based drug (Epidiolex) that the U.S. Food and Drug Administration has approved, it has become an even more attractive growth stock with tremendous upside.

While investors weren't pleased with the company's recent earnings report, which sent shares off a cliff, there's plenty of reason to remain bullish on the stock. And given that shares of Jazz are trading at the lowest price they've fetched all year, now may be a great time to consider buying it.

On June 22, 2021, Governor Lamont signed the Act Concerning Responsible and Equitable Regulation of Adult-Use Cannabis into law, legalizing the use of recreational marijuana in our state.

The new law allows adults (21 and older) to have on their person up to 1.5 ounces of marijuana or have up to 5 ounces in a locked container. It also allows for the expungement of some marijuana-related convictions, sets up a framework for businesses to apply for licenses to grow, manufacture, retail and distribute, and carries out restrictions on employers and protections for employees.

Jazz Pharmaceuticals subsidiary GW Pharmaceuticals has announced it has received approval in the UK for the use of Epidyolex to manage seizures associated with tuberous sclerosis complex (TSC).

Tuberous sclerosis complex is a rare genetic disease causing benign tumours to grow in the brain and on other vital organs. Among its many impacts where the condition is severe are seizures and impaired intellectual development. The seizures are often resistant to conventional therapies.

Usually diagnosed in early childhood, the number of people living with TSC in the UK is estimated between 3,700 and 11,000.

GW Pharmaceuticals’ cannabidiol-based Epidyolex (known as Epidiolex in the USA) is already in use in the UK for seizures associated with Lennox Gastaut syndrome (LGS) and Dravet syndrome. In September last year, the Australian Therapeutic Goods Administration (TGA) approved it here for the same indications.

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has now also approved it for TSC as an adjunct therapy to be used in conjunction with clobazam (a benzodiazepine class medication), for patients two years of age and older.

The California Supreme Court ruled this week that inmates in the state prison system do not have a right to possess marijuana under Proposition 64, the landmark 2016 ballot initiative that legalized cannabis in the state. The ruling overturns a lower court decision in 2019 that found that prisoners could possess marijuana but could not smoke or otherwise ingest it while behind bars.

“It seems implausible” that the voters intended to essentially decriminalize marijuana in prisons with the ballot measure’s passage, Associate Justice Joshua Groban wrote in the court’s majority opinion.

2019 Decision Overturned For California Inmates

The Supreme Court’s decision was handed down in a case of five men who were convicted of marijuana possession after being found with cannabis in their prison cells. In 2019, California’s 3rd District Court of Appeal ruled that although smoking and ingesting marijuana in prison is illegal under state law, possession of cannabis was not specifically outlawed by statute. Under that ruling, the appeals court found that state prisoners could legally possess up to one ounce of marijuana. Other appeals court decisions, however, had found that marijuana possession in prisons is still against the law.

“We agree with the Attorney General that if the drafters had intended to so dramatically change the laws regarding cannabis in prison, we would expect them to have been more explicit about their goals,” wrote Groban.

“While perhaps not illogical to distinguish between the possession and use of cannabis, it is nonetheless difficult to understand why the electorate would want to preclude laws criminalizing cannabis possession in prison, but permit laws criminalizing cannabis consumption in prison,” he continued.

CALGARY -- The death of 15-year-old Mia Wilkinson has rocked her family and friends, the teen girl passed away suddenly on August 12.

“It really hits home and it's gut wrenching,” said Kendra Myhre, a long-time friend of the family.

“I am so upset and hurt and devastated.”

Mia was diagnosed with Ohtahara syndrome when she was a baby, which causes her to have severe seizures and sometimes she could have up to 100 episodes every day. When Mia was about seven years old, her mom Sarah explored cannabis oil and it changed Mia’s life.

Since then, Sarah has worked to educate and counsel other families about the benefits of cannabis for children who suffer from severe seizures.

DETROIT, Aug. 16, 2021 /CNW/ - Gage Growth Corp. ("Gage" or the "Company") (CSE: GAGE) a leading high-quality cannabis brand and operator in Michigan, today announced their third social equity grant recipient, Margaeux Bruner, Founder of Holi Smokeables, who will be awarded the grant for her product The Holi Flower, an exclusive hemp wrap cone.

"Michigan is a state that has been deeply impacted by the tragic effects of the War on Drugs. Social equity initiatives like Gage's generous grant program provide Black-owned businesses with a more level playing field to compete with deep-pocketed operators in their community," said Bruner. "We are grateful to receive this grant from Gage in order to bring unparalleled and innovative quality hemp products and accessories to the Michigan market."

Bruner founded Holi Smokeables in December 2020 and will launch the Holi hemp wrap cone in August. The company specializes in sustainable hemp paper products and accessories that honor the ethos of the flower. Prior to founding Holi Smokeables, Michigan's Attorney General, Dana Nessel, selected Bruner to serve on the state's Marijuana Legal Workgroup, which worked to ensure that the state's marijuana proposals and regulations are fairly, equally and appropriately implemented. Bruner also previously served as the Commissioner of the Impaired Driving Safety Committee, representing qualified and registered patients. During the 2018 Coalition to Regulate Marijuana Like Alcohol campaign, Bruner served as a Designated Speaker and Strategist on behalf of the Marijuana Policy Project. She will be speaking at the National Cannabis Festival on August 28, 2021, as well as the NECANN Boston event on September 12, 2021.

"Our social equity program is committed to not only making Michigan's cannabis industry more accessible to entrepreneurs but also amplifying the exceptional talents that make up our business community," said Fabian Monaco, CEO of Gage. "Margaeux is a tremendous business leader, and we are confident in her ability to leverage this grant to build Holi Smokeables into an impactful brand."

"We are thrilled to name Margaeux Bruner as our third social equity recipient," said Sydney Bowden, Community Coordinator at Gage. "In addition to her company being an asset to the retail sector, Bruner has been a tireless advocate for social equity in cannabis and in Michigan. We look forward to watching her grow this new venture and supporting other businesses like hers through our grant efforts."

London, UK, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Link Reservations Inc. (OTC Pink: LRSV) (the “Company”), a provider of medicinal mushroom and cannabidiol (CBD) wellness products for both humans and pets, announces its LinkResPet and DailyLifeCBD products will be available for purchase in all four retail locations of Collins Tobacco & Vape Stores. This comes as the Company looks to expand its presence across the marketplace and increase consumer awareness of its pet and human wellness products.

Rene Lauritsen, Link Reservations Inc CEO, commented: “We are very excited to have our products in all four Collins Tobacco & Vape retail locations. In the next few months we hope to continue this growth and have a stronger presence in retail locations across the U.S. and eventually in the Europe and the UK. This is a great way to increase product awareness amongst consumers who are already interested in CBD products but haven’t come across our products before. Retail presence for us is clearly a key driver of sales as we look to grow our market share. I look forward to updating investors on any further developments”.

LinkResPet’s products consist of CBD tinctures for dogs and cats. While DailyLifeCBD has a functional mushroom and CBD range of products including its DailyLifeCBD Immune tincture, as well as other CBD products in the pipeline. All products are made with the highest quality hemp oil and are lab tested, THC and GMO free. The hemp oil used in LRSV products comes from organically grown certified U.S. and European hemp. The Company ensures that its products undergo a rigorous process of quality control and testing using the latest scientific methods.

Collins Tobacco & Vape has been in business 12 years and has four locations in Miami & Miami Beach. These are 6750 Collins Ave Miami Beach, 2611 Collins Ave Miami Beach, 1711 N. Bayshore Dr Miami (Grand Hotel) and 2504 NE 2nd Ave Miami.

For more information about LinkResPet or to purchase CBD products for pets, please visit www.linkrespet.com or follow us on Twitter @res_pet

Individual consumers in Arizona seem to be safe in possessing it. The Smart and Safe Act that voters approved last year allows people 21 and older to legally have five grams or less of any marijuana concentrate. That includes a Delta 8 gummy or vape cartridge.

The first thing to know about the increasingly popular cannabinoid called Delta 8 THC is that, unlike CBD, it will get you high.

How high? The internet is replete with articles and videos that attempt to detail and describe the difference between a Delta 8 buzz and that of normal marijuana, which contains Delta 9 THC. The overall verdict is that Delta 8 won't get you as intensely high as normal Delta 9 weed. Some estimates declare it 55 to 75 percent as potent as Delta 9. This has led people to call it "marijuana lite" or market it as a type of pot that provides a more clear-headed, less-impairing buzz.

The second thing to know about Delta 8 is that its legality is complicated, much like the cannabis plant from which it's extracted.

But business operators selling Delta 8 could be taking a risk. Due to its unforeseen rise in popularity over the last year, state and federal laws are ill-equipped to deal with this new chemical compound.